Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Jun 17, 2025
Open Peer Review Period: Jun 18, 2025 - Aug 13, 2025
Date Accepted: Aug 20, 2025
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Testing Theory-Enhanced Messaging to Promote COVID-19 Vaccination Among Adults: Randomized Controlled Trial

Piltch-Loeb R, Shen Y, Fleary S, Robertson M, Nuñez Sahr J, Penrose K, Sanborn J, Yadav S, Srivastava A, Nash D, Parcesepe A

Testing Theory-Enhanced Messaging to Promote COVID-19 Vaccination Among Adults: Randomized Controlled Trial

J Med Internet Res 2025;27:e79228

DOI: 10.2196/79228

PMID: 41057045

PMCID: 12541261

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Testing Theory-Enhanced Messaging to Promote COVID-19 Vaccination: Results from a Randomized Controlled Trial

  • Rachael Piltch-Loeb; 
  • Yanhan Shen; 
  • Sasha Fleary; 
  • McKaylee Robertson; 
  • Josefina Nuñez Sahr; 
  • Kate Penrose; 
  • Jenna Sanborn; 
  • Surabhi Yadav; 
  • Avantika Srivastava; 
  • Denis Nash; 
  • Angela Parcesepe

ABSTRACT

Background:

Uptake of the COVID-19 vaccine has been low in the US (about 22% among adults in 2023-241) despite ongoing public health recommendations. This has been linked to many factors including pandemic fatigue, reduced risk perception, dis/misinformation, and more recently, to symptoms of depression and anxiety. Novel communication and messaging strategies are one potential approach to promote vaccine uptake.

Objective:

Randomized control trial testing two communication-based approaches compared to standard public health messaging on vaccine uptake in a cohort of adult US residents.

Methods:

We completed a 3-arm, parallel-group, assessor-blinded stratified-randomized trial between April-15-2024 and May-2-2024. Eligible individuals were ≥18 years old who: 1) had received at least one dose of the COVID-19 vaccine, but, 2) had not received COVID-19 vaccine doses since September-11-2023, and 3) had not been infected with SARS-CoV-2 in the past three months. We purposively sampled eligible individuals with and without symptoms of anxiety and depression. Participants were randomly allocated to: 1) attitudinal inoculation intervention; 2) CBT-kernels intervention; or 3) standard public health messaging intervention.

Results:

At four-week follow up, these groups showed no meaningful differences in uptake (CBT- kernels:1.6% [95%CI:0.4-2.8]; Inoculation:0.9% [95%CI:0.0-1.8]; and Standard:1.3% [95%CI:0.3-2.4]) or level of vaccine willingness.

Conclusions:

Successful efforts to increase uptake of the COVID-19 vaccine via theory-enhanced messaging remain elusive. Clinical Trial: Protocol NCT06119854


 Citation

Please cite as:

Piltch-Loeb R, Shen Y, Fleary S, Robertson M, Nuñez Sahr J, Penrose K, Sanborn J, Yadav S, Srivastava A, Nash D, Parcesepe A

Testing Theory-Enhanced Messaging to Promote COVID-19 Vaccination Among Adults: Randomized Controlled Trial

J Med Internet Res 2025;27:e79228

DOI: 10.2196/79228

PMID: 41057045

PMCID: 12541261

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.